We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Reach Separations

News List

Reach Separations Expands Nottingham Premises contractpharma
November 05, 2020
Early-stage drug discovery, purification specialist and contract research organization (CRO) Reach Separations has expanded its Nottingham premises in the wake of increased demand for its chiral purification services.
Four UK CROs announce collaboration to work on potential COVID-19 therapeutics europeanpharmaceuticalreview
May 20, 2020
A group of four CROs at BioCity Nottingham have joined forces to collectively work on the research of COVID-19 therapies.
Reach Separations celebrates fifth birthday with record year pharmaasia
February 20, 2017
A UK-based purification specialist has marked its fifth anniversary with a record year of growth in demand for its small molecule synthesis capabilities